v3.26.3
RESEARCH AND DEVELOPMENT EXPENSES
12 Months Ended
Dec. 31, 2025
RESEARCH AND DEVELOPMENT EXPENSES  
RESEARCH AND DEVELOPMENT EXPENSES

NOTE 23 – RESEARCH AND DEVELOPMENT EXPENSES

 

Research and development expenses, excluding stock-based compensation, depreciation and lease amortization expenses, allocated to our major research and development programs are as follows:

 

In Thousands of US Dollars

 

 

For the Year Ended December 31,

 

Research and Development Program

 

2025

 

 

2024

 

 

2023

 

Research and Development Program

 

$-

 

 

$-

 

 

$-

 

Alzheimer’s Disease: Therapeutics

 

 

-

 

 

 

-

 

 

 

-

 

Anti-Infectives

 

 

-

 

 

 

-

 

 

 

-

 

BPH (Enlarged Prostate) and Prostate Cancer Therapeutics

 

 

1,223

 

 

 

2,910

 

 

 

2,763

 

Tobacco Exposure Tests: NicAlert™ and TobacAlert™

 

 

-

 

 

 

-

 

 

 

-

 

Total

 

$1,223

 

 

$2,910

 

 

$2,763